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SYNOPSIS

The thesis entitled ‘A FACILE SYNTHESIS OF BIOLOGICALLY ACTIVE PHTHALIMIDES & ITS ANALOGUES-A STUDY‘ is divided into four chapters.
	The title of the thesis clearly reflects the objective, which is to synthesize some biologically relevant drugs containing N-phthaloyl moiety and phthalimide derived compounds and evaluation of their biological activity. Chapter I describes the general introduction of phthalimides and their biological importance; synthetic procedure developed in comparision to earlier procedures and application to the synthesis of N-phthaloyl linked 3-thiazolo substituted coumarines and evaluation of their antimycobacterial and antimicrobial activities. Chapter II deals with the drugs containing              N-phthaloyl moiety such as synthesis of racemic Thalidomide, anti-HIV agent via Na/Liq.NH3 mediated cyclization strategy and drugs derived from phthalimide moiety, eg., synthesis of racemic and enantioselective synthesis of R-Baclofen, a novel GABAB receptor agonist via preparation of                      N-phthalimido acetaldehyde in situ by ozonolysis of N-allyl phthalimide, and subsequent 2-carbon Wittig reaction. Thus formed ester is reacted with 4-chloro boronic acid using Rh-BINAP as chiral reagent. Chapter III presents the synthesis and characterization of glycine and mandelic Acid derived phthalimides of biologically relevance (such as anti-microbial and anti-inflammatory). Chapter IV deals with the synthesis of synthesis and applications of N-phthaloyl aminoacids in the preparation of                               1,5-benzodiazepines acting as Lewis acids, synthesis of novel chiral oxazolines and N-phthaloyl L-aminoacid derived ligands by innovative strategies and chiral oxazoline and chiral Schiff base tetradentate ligand using phthaloyl protecting and deprotecting strategy.
CHAPTER I- Chemistry of Phthalimides
      Among heterocyclic scaffolds, phthalimides are of particular biological interest and have been reported as herbicides, insecticides, antipsychotics and antiinflammatory agents. Phthalimide derivatives with phenyl acetic acid and phenyl propionic acid were found to possess anti inflammatory and analgesic properties. Substituted phthalimides are used predominantly as chiral building blocks in organic synthesis and can be used as key intermediates in the preparation of bio-active compounds i.e. antibacterial, analgesic, antifungal, virucidal, plant growth regulator and also in dye industry.
The use of phthalimides as primary amine protecting groups is extensively documented in the chemical literature, especially for –amino acids. N-Phthaloyl derivatization is one of the most frequently used methods of protection in the synthesis involving compounds with primary amino groups.  In addition, the photophysical properties of phthalimides have been studied intensively during the last two decades.
     While there are several synthetic procedures for preparing these compounds, limitations as noted below were found. (1) Most of the known procedures for phthalimide formation are compatible only with simple alkyl or aryl substituents on the nitrogen atom. (2) It is difficult to introduce a functional group, especially an electron-donating group, on the phenyl ring of phthalimides. (3) The formation of imide usually requires high reaction temperatures. (4) The use of expensive catalysts (Pd or Ni etc). Thus in order to minimize the usage of raw materials and effluent, product formation should proceed with high levels of atom economy and selectivity.  
      	In view of the tremendous importance of phthalimides, we herein describe an efficient approach for the synthesis of phthalimide derivatives.
Using almost stoichiometric quantities of phthalic anhydride (1 eq.) and substituted amines (1.1 eq) suspended in methanol for the condensation to take place (Scheme 1). The reaction mixture was heated on water bath for the time given to the corresponding amines as shown in Tables 1 and 2, at              50-60 0C. Added catalytic amount of 10% aq. NaOH solution for the cyclization of the formed N-phthalamic acids. The mixture was left at the room temperature for overnight and resultant products are formed as crystals. Subsequnt reduction and condensation with appropriate reagent, results in the synthesis of biologically active phthalimide derivatives.
Scheme 1



Structurally and electronically divergent amines were deliberately chosen for the condensation with phthalic anhydride to know the efficacy of present methodology (Table 1).
Table 1. Reaction of phthalic anhydride with structurally divergent amines.
Entry	Amine	Product	Time (min/h)	Isolated yield (%)
1	Cyclohexyl amine (2a)	3a 	2.5 h	72
2	Aniline (2b)	3b 	45 min	87
3	4-Methyl aniline (2c)	3c	1 h	65
4	Benzyl amine (2d)	3d	45 min	78
5	4-Methoxy aniline (2e)	3e	1.2 h	76
6	4-Nitro aniline (2f)	3f	30 min	92
7	4-Chloro aniline (2g)	3g	1 h	81
8	1-(4-Aminophenyl)-1-ethanone (2h)	3h	0.75 h	94
9	     2-(2-Aminophenyl)acetic acid (2i)	3i	2.5 h	88
10	2-Cyano aniline (2j)	3j	45 min	95
11	    1H-Benzo[d]imidazol-2-amine (2k)	3k	1.45 h	68
12	   2-Chloro-1-ethanamine (2l)	3l	1.25 h	61
13	   2-Aminoethyl cyanide (2m)	3m	1.75 h	75
14	     2-Aminoethyl methyl sulfite (2n)	3n	1.5 h	80
15	1-(2-Aminoethyl)-1,2-triazadien-2-ium (2o)	3o	6 h	67
16	     4-Chloro-3-fluoroaniline (2p)	3p	1.25 h	47
17	1,3-Benzothiazol-2-ylmethanamine (2q)	3q	3.5 h	56
18	tert-Butyl carbamate (2r)	3r	2 h	82
19	2-Amino-1-ethanol (2s)	3s	5 h	95
20	     1H-1,2,3,4-Tetraazol-5-amine (2t)	3t	2 h	92

We have studied the functional group tolerance of our developed protocol, using different protected amines. It was noteworthy that, in all cases, -OH, -Cl, -OMs, -CN and -N3 functional groups remained unaffected for the facile condensation to take place. It was also worthwhile to note that good yields could be achieved with different heterocyclic amines such as 1H-benzo[d]imidazol-2-amine (2k), 1,3-benzothiazol-2-ylmethanamine (2q), 1H-1,2,3,4-tetraazol-5-amine (2t) etc. 
Apart from the compounds synthesized in Scheme 1, some novel                        N-phthaloyl linked 3-thiazolo substituted coumarines were also prepared (Scheme 2 and entries 5a-g, Table 2) because of the tremendous importance of the coumarine nucleus which is found in a variety of natural products and exert varied pharmacological effects. There were some limitations for the developed protocol. Amino acids were not tolerated under the present conditions. Base induced racemization was observed for the preparation of N, N-phthaloyl aminoacids.
Scheme 2

Table 2. Reaction of phthalic anhydride with structurally divergent 3-thiazolo substituted coumarines.
Entry	Amine (4a-g)	Product	Time (h)	Isolated yield (%)
1	 4a	5a(ASR-T-01)	4 	82
2	4b	5b(ASR-T-02)	6 	78
3	4c	5c(ASR-T-03)	7 	90
4	4d	5d(ASR-T-04)	4.5 	89
5	4e	5e(ASR-T-05)	5	74
6	4f	5f(ASR-T-06)	12	58
7	          4g	5g(ASR-T-07)	8.5	62

We have subjected the compounds (entries 5a-g, Scheme 2) for anti-mycobacterial screening done in TAACF screening programme for the discovery of novel drugs for treatment of mycobacterial infections, Alabama, 
USA and antimicrobial screening as well.

CHAPTER II- Synthesis of Thalidomide and  ()-and (R)-Baclofen
This chapter is divided into two sections. Section-A deals with the racemic synthesis of thalidomide and Section-B deals with the racemic and enantioselective approaches to the synthesis of Baclofen.
Section A: Synthesis of Thalidomide (Anti-HIV/Anti-Leprosy Drug)
Thalidomide (1) has a relatively simple chemical architecture (Figure 1), but exhibits a multitude of physiological activities (as multitarget drug) on mammals.
Figure 1

Considering the newly discovered activity of the drug in treating infectious diseases and being interested in exploring novel routes for the preparation of the phthalimide and arylalkanoic acid derived drugs and analogues, we wish to report two novel methods of synthesizing thalidomide. 
Treatment of 1 with thionyl chloride in methanol under reflux for 6 h afforded after usual workup afforded N-phthaloyl L-glutamic acid dimethyl ester 2 as an oil (71%). The following key step is based on the formation of the glutarimide ring from glutaric acid diesters by using the NaNH2/liq.NH3/Fe(NO3)3 methodology. To our satisfaction, the ester 2 was cyclized to give the desired compound 6 in a low yield (Scheme 3). 

Albeit the chemical yield is low, the above two-step synthesis encouraged us to explore the applicability of this methodology in the large scale synthesis of thalidomide using an alternative strategy starting from L-GA. A facile, efficient, concise, cost effective and scalable synthesis of thalidomide in high overall yield (55%) is presented. Treatment of Boc-protected L-glutamic acid diester via Na/liq.NH3 (-33 0C) mediated cyclization methodology, produces corresponding glutarimide ring which was subsequently condensed with phthalic anhydride in presence of glacial acetic acid to afford thalidomide and related analogues (Scheme 4).
In summary, the practical short synthesis was developed as an alternative to the previous syntheses of thalidomide using NaNH2/liq. NH3 methodology for the first time, found to fulfill our initial requirements of economical and readily available starting materials, high overall yield and ability to be done on multi-gram scale. No exceptional purification (such as use of high melt temperatures, acidic purifications) was required for all intermediates and reagents. General applicability of this methodology could be easily extended to other analogues of thalidomide.


Section B: Formal Synthesis of ()-Baclofen via Pd(II)-Bipyridine  Catalyzed  Conjugative Addition and Enantioselective Synthesis of (R)-           (–)-Baclofen, a Novel GABAB Receptor Agonist, via Rh/BINAP Conjugative Addition
Baclofen [-amino--(p-chlorophenyl)butyric acid, 1] is a derivative of -aminobutyric acid (GABA). It plays an important role as an inhibitory neurotransmitter in central nervous system (CNS) of mammalians.
R-Baclofen, or (3R)-4-amino-3-(4-chlorophenyl)butanoic acid, (1a, Fig. 2), is the only selective and therapeutically available GABAB agonist known (Lioresal® and Baclon®). Baclofen is commercialized in its racemic form, however literature observations suggested that the biological activity of 1a resides in the R enantiomer. According to legislation already approved in many countries of the world concerning the commercialization of pharmaceutical products, drugs such as 1a will soon be sold only in their enantiomerically pure form. This requirement justifies the need for enantioselective strategies leading to the preparation of these compounds, if possible in a simple and efficient way.
Figure 2

Considering its biological and pharmacological activity of the drug and being interested in exploring novel routes for the preparation of the phthalimide and arylalkanoic acid derived drugs and analogues, we continued our studies using a novel approach for the synthesis of racemic Baclofen and finally Rh/BINAP catalyzed conjugative addition of                        p-chloroboronic acid to achieve enantioselective synthesis of (R)-Baclofen.
Since, this section deals with two important strategies recently developed for the conjugate addition of ,-unsaturated esters, i.e., a) Pd (II)-Bipyridine-catalyzed catalyzed conjugative addition in the presence of 2,2’-bipyridine and b) introducing stereogenicity into the prochiral molecule via Rh/BINAP-catalyzed conjugative addition, a brief account of each was presented in the particular section.
The synthetic strategy for both the syntheses of (R,S)-Baclofen and (R)-(-)-Baclofen was shown in Scheme 5 wherein both the above key steps are essential for the completion of total synthesis of racemic and (R)-Baclofen.
The synthesis commenced with the preparation of N-allyl phthalimide 72 as outlined in Scheme 5.
Scheme 5

Compound 72 then was subjected to ozonolysis to give compound                                               N-phthalimidoacetaldehyde (73) as crystalline white solid which was further was subsequently treated with PPh3CHCOOC2H5 (74) in dry DCM at room temperature to give the requisite ethyl (2E)-4-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)but-2-enote (75) as colourless crystals. Next, the reaction conditions of the Pd(OAc)2/bipy catalyzed 1,4-conjugative addition were optimized for the synthesis of 76, a key intermediate using standard reaction conditions, to afford compound 76. 
Above prepared phthalimide protected ,-unsaturated ester (75) was used as the common precursor for the enantioselective synthesis of (R)-Baclofen 
using Rh(I)-catalyzed asymmetric conjugate addition of chloroboronic acid as a key step. The reaction conditions of the 1,4-addition were optimized for the synthesis of 76a using first standard reaction conditions, i.e. 3 mol% of commercially available [Rh(acac)(C2H4)2], 4.5 mol% of  (S)-BINAP and Na2CO3 at 100 0C for 2 days. Deprotection of the addition product 76 or 76a to give baclofen hydrochloride was performed in 45% yield by treatment with hydrazine hydrate in 80% hydrazine hydrate and ethanol under reflux conditions for overnight, followed by addition of HCl, affording the desired product 1 and 1a.
In the present study, a novel, productive approach for the synthesis of baclofen (1) in five steps with 22% overall yield via Pd(OAc)2/bipy catalyzed conjugative addition of N-phthaloyl ,-unsaturated ester 75 with                       4-chlorophenylboronic acid as a key step was studied. Further, synthesis of R-baclofen (1a) in chiron approach using Rh/BINAP asymmetric conjugate addition was also successfully achieved.
CHAPTER III- Glycine & Mandelic Acid Derived Phthalimides
This chapter is divided into two sections. 
Section-A deals synthesis, charecterization and biological activities of                   N-Phthaloyl glycine derived functionalized piperazines and 2-(2-oxo-2-phenylethyl)-1,3-isoindolinedione derivatives. Section-B presents the synthesis of mandelic acid derived phthalimides as a new class of anti-inflammatory and antimicrobial agents. 
Section A: Study on N-Phthaloyl Glycine Derived Functionalized ketones
and Evaluation of Anti-Microbial Activity
      Glycine and -aminobutyric acid (GABA) are inhibitory amino acid neurotransmitters in the brain.  There are several reports pertaining to the biological activities of N-phthaloyl glycine derivatives. Piperazines and their keto analogues are amongst the most important backbones in today’s drug discovery industries. Owing to the high number of positive hits encountered in biological screens with this heterocycle and its congeners, the piperazine template certainly deserves the title of “privileged scaffold’’ in medicinal chemistry. 

      Moreover, the piperazine scaffold occurs regularly in complex natural products. Thus, it is no wonder that there is a plethora of different synthetic methods that allow for the fast and efficient assembly of these heterocyclic systems. 
These findings clearly indicate that N-phthaloyl aminoacid conjugates linked through piperazine moiety side arm with alkane spacers may exhibit good pharmacological activities. A new series of N-phthaloyl glycine derived functionalized piperazines (6a-k) were envisaged, resulting from the combination of N-phthaloyl glycine chloride (4) and structurally divergent piperazines (5a-k) with potent antimicrobial activity (Scheme 6).
Apart from the synthesis of N-phthaloyl glycine derived functionalized piperazines (6a-k), N-phthaloyl functionalized aryl ketones were also synthesized (Scheme 7).

      The synthesized compounds [(6a-k) and (10a-j)] were evaluated for in vitro antibacterial as well as antifungal activities.
Section B: Synthesis, Characterization and Biological activities of Mandelic Acid Derived Phthalimides as a New Class of Anti-inflammatory and Antimicrobial Agents
Phthalimide derivatives with phenyl acetic acid and phenyl propionic acid were found to possess anti inflammatory and analgesic properties.                 N-Hydroxyethyl phthalimide is used as an intermediate in some drugs, dyes and pesticides.
Aromatic hydroxy acids and its derivatives are important biologically and display a range of physiological effects. One such example is the application of mandelic acids in the production of -lactam antibiotics. A vast literature review reveals that mandelic acid and its derivatives showed anti oxidant, urinary antiseptic, anti HIV, antitumor, antifungal, anti-thrombic effects.
A new hybrid series of 2-(1,3-dioxo-2,3-dihydro-1H-2-isoindolyl) ethyl 2-hydroxy-2-(substituted) acetates (6a-d) were envisaged  resulting from the combination of N-(2-hydroxy ethyl) phthalimide (5) and substituted mandelic acids (2a-d) as seen, would result in compounds with potent antimicrobial and anti-inflammatory activities (Scheme 8).


Chapter IV- Synthesis & Applications of N-Phthaloyl Aminoacids
Divided into three sub sections. Section-A deals with the synthesis f                       N-phthaloyl aminoacids and their application in organic synthesis. Section-B presents the synthesis of N-phthaloyl L-phenyl alanine based chiral oxazoline Section-C descripts the novel chiral Schiff base ligand from N-Phthaloyl L- phenyl alanine derived amides and salicylaldehyde.
Section A: Synthesis of N,N-Phthaloyl Amino Acids and their Application as Lewis Acids for the Synthesis of 1,5-Benzodiazepines
A brief description of earlier syntheses to N-phthaloyl aminoacids and their application in organo catalysis was discussed by synthesizing N,N-phthaloyl aminoacids with sufficient spectral characterization. 
Thus, prepared N,N-phthaloyl aminoacids could be used as Lewis acid promoters by developing a practical procedure for the synthesis of 2,3-dihydro-1H-1,5-benzodiazepines at ambient temperature using N-phthaloyl L-phenyl alanine (NPPA) in acetonitrile. Due to their accessibility, easy functionalization and potential pharmacological properties, mainly 1,5-benzodiazepine derivatives have received significant attention and the core is indeed a ‘‘privileged scaffold’’.
The advantages of the present protocol were mild, short reaction times, study of wide range of electronically divergent substrates, easy work-up, low toxicity, inexpensive, and readily preparable catalyst, that make the procedure an attractive alternative to the existing methods for the synthesis of 1,5-benzodiazepines and can be applied to other organic transformations as well (Scheme 9). 


Section B: Synthesis of N-Phthaloyl L-Phenylalanine Derived Chiral Oxazoline (1)
The development of new classes of chiral ligands for metal catalyzed asymmetric transformations is an important goal of contemporary organic chemistry. Chiral oxazoline-based ligands are one of those ligands which have attracted significant attention over the past two decades for their potential application in a variety of catalytic asymmetric reactions including diethylzinc addition, allylic alkylation, cyclopropanation, hydrosilylation, olefin hydrogenation, transfer hydrogenation of ketones, and Diels-Alder reactions etc. 
In an effort to explore new oxazoline ligand templates for catalytic enantioselective reactions, we have targeted cost-effective N-phthaloyl L-phenyl alanine derived oxazoline amine (Scheme 10). 

The synthetic plan of the oxazoline includes: N-Phthaloylation of various aminoacids and condensing with the divergent chiral aminoalcohols and subsequent cyclization followed by deprotection to give the desired oxazoline 1. Thus obtained ligands are being investigated for various catalytic asymmetric reactions.
Thus, an elegant description of applications of chiral oxazolines in asymmetric catalysis and recently developed as well as earlier approaches for the synthesis have been aptly described in this section. Apart from that, the synthesis of chiral oxazoline 1 (1S)-1-[(4S)-4-benzyl-4,5-dihydro-1,3-oxazolo-2-yl]-2-phenylethan-1-amine) as a new class of bidentate ligands, designed from N-phthaloyl L-phenyl alanine, was successfully accomplished.
Section-C:  Section C: Synthesis of N-Phthaloyl L-Phenylalanine Derived Chiral Schiff Base Ligand 
The synthesis of new kind of chiral ligands represents one of the most important factors in the field of asymmetric catalysis. The major parts of most common ligands are bidentate and neutral, like DIOP and BINAP, or dianionic, like TADDOL and BINOL. The chiral chelating ligands that afford metal centres with a chiral environment are essential components for the development of chiral catalysts. Over the past 25 years, extensive chemistry has surrounded the use of Schiff base ligands in inorganic chemistry.
The present work reports the synthesis and spectroscopic characterization of novel symmetric N-salicylaldehyde ligands using                   N-phthaloyl protecting and deprotecting strategies (Scheme 11). 

      	The synthesis was carried out in four easy steps, each with excellent or good yields. At first, employing N-phthaloyl protected L-phenylalanine 2, as starting material, the corresponding diamide adduct 3 was obtained in 90% yield. The N-phthaloyl functions of 3 were cleaved (82% yield) with an ethanolic 80% aq.hydrazine hydrate at reflux for 2.5 h and followed by usual work up. The synthesis of the desired ligands was accomplished by condensation of chiral diamine 4 with salicylaldehyde under reflux in MeOH, followed by crystallization of the corresponding Schiff base 1 in 58% yield.
A short synthesis of a new class of chiral polydentate Schiff base ligand 1, containing mixed N,O donors was developed. This ligand was easily prepared in good yield starting from low-cost commercially available materials. In fact coordinating the ligand to lanthanides to use in asymmetric catalytic processes would not only has great significance in the fundamental chemistry of these rare earth elements but could also have an important role in the field of MRI contrast agents, biological probes or NMR chiral shift reagents.
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